Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Rangering i aksjer #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Aksjekurs
$3.11
Markedsverdi
$1.41B
Endring (1 dag)
-1.97%
Endring (1 år)
-57.22%
Land
CN
Handel Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategori

Aksjeprishistorikk for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Høyeste sluttskurs: $3.38 den 2026-08-01

Laveste sluttskurs: $1.01 den 2011-04-01
Aksjeprishistorikk for Staidson (Beijing) BioPharmaceuticals Co., Ltd. fra 2011 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 5.61%
2025 251.84%
2024 -26.03%
2023 -29.22%
2022 -22.33%
2021 84.25%
2020 -2.73%
2019 -4.89%
2018 -25.27%
2017 -17.93%
2016 -37.14%
2015 89.87%
2014 4.94%
2013 1.98%
2012 47.53%
2011 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$541.63 38.15%
US
$1.03K 45.67%
NL
$121.53 -12.48%
AU
$137.73 462.87%
US
$759.27 6.90%
CH